Prediction of residual metabolic activity after treatment in NSCLC patients

Author： Velazquez Emmanuel Rios Aerts Hugo J. W. L. Oberije Cary De Ruysscher Dirk Lambin Philippe

ISSN： 0284-186X

Source： Acta Oncologica, Vol.49, Iss.7, 2010-10, pp. : 1033-1039

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Does VMAT for treatment of NSCLC patients increase the risk of pneumonitis compared to IMRT ? – A planning study

By Bertelsen Anders Hansen Olfred Brink Carsten

Acta Oncologica, Vol. 51, Iss. 6, 2012-07 ,pp. : 752-758

Informa Healthcare

Access to resources Recommend Favorite

Predictive and prognostic factors in second- and third-line erlotinib treatment in NSCLC patients with known status of the EGFR gene

Oncology Reports, Vol. 30, Iss. 3, 2013-01 ,pp. : 1463-1472

Spandidos Publications

Access to resources Recommend Favorite

Intensity-modulated stereotactic radiotherapy for the treatment of medically inoperable patients with NSCLC stage I

Oncology Reports, Vol. 28, Iss. 4, 2012-01 ,pp. : 1309-1314

Spandidos Publications

Access to resources Recommend Favorite

Margin Index: A New Method for Prediction of Residual Disease After Breast-Conserving Surgery

By Margenthaler Julie

Annals of Surgical Oncology, Vol. 17, Iss. 10, 2010-10 ,pp. : 2696-2701

Springer Publishing Company

Access to resources Recommend Favorite

Metabolic profile, physical activity, and mortality in breast cancer patients

By Emaus Aina Veierød Marit Tretli Steinar Finstad Sissi Selmer Randi Furberg Anne-Sofie Bernstein Leslie Schlichting Ellen Thune Inger

Breast Cancer Research and Treatment, Vol. 121, Iss. 3, 2010-06 ,pp. : 651-660

Springer Publishing Company

Access to resources Recommend Favorite